Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Letter
  • Published:

Chymotrypsin C (CTRC) variants that diminish activity or secretion are associated with chronic pancreatitis

Abstract

Chronic pancreatitis is a persistent inflammatory disease of the pancreas, in which the digestive protease trypsin has a fundamental pathogenetic role. Here we have analyzed the gene encoding the trypsin-degrading enzyme chymotrypsin C (CTRC) in German subjects with idiopathic or hereditary chronic pancreatitis. Two alterations in this gene, p.R254W and p.K247_R254del, were significantly overrepresented in the pancreatitis group, being present in 30 of 901 (3.3%) affected individuals but only 21 of 2,804 (0.7%) controls (odds ratio (OR) = 4.6; confidence interval (CI) = 2.6–8.0; P = 1.3 × 10−7). A replication study identified these two variants in 10 of 348 (2.9%) individuals with alcoholic chronic pancreatitis but only 3 of 432 (0.7%) subjects with alcoholic liver disease (OR = 4.2; CI = 1.2–15.5; P = 0.02). CTRC variants were also found in 10 of 71 (14.1%) Indian subjects with tropical pancreatitis but only 1 of 84 (1.2%) healthy controls (OR = 13.6; CI = 1.7–109.2; P = 0.0028). Functional analysis of the CTRC variants showed impaired activity and/or reduced secretion. The results indicate that loss-of-function alterations in CTRC predispose to pancreatitis by diminishing its protective trypsin-degrading activity.

This is a preview of subscription content, access via your institution

Access options

Rent or buy this article

Prices vary by article type

from$1.95

to$39.95

Prices may be subject to local taxes which are calculated during checkout

Figure 1: Effects of pancreatitis-associated CTRC variants on the secretion of chymotrypsinogen C.

Similar content being viewed by others

Accession codes

Accessions

GenBank/EMBL/DDBJ

Protein Data Bank

References

  1. Whitcomb, D.C. et al. Hereditary pancreatitis is caused by a mutation in the cationic trypsinogen gene. Nat. Genet. 14, 141–145 (1996).

    Article  CAS  Google Scholar 

  2. Gorry, M.C. et al. Mutations in the cationic trypsinogen gene are associated with recurrent acute and chronic pancreatitis. Gastroenterology 113, 1063–1068 (1997).

    Article  CAS  Google Scholar 

  3. Teich, N., Mössner, J. & Keim, V. Mutations of the cationic trypsinogen in hereditary pancreatitis. Hum. Mutat. 12, 39–43 (1998).

    Article  CAS  Google Scholar 

  4. Witt, H., Luck, W. & Becker, M. A signal peptide cleavage site mutation in the cationic trypsinogen gene is strongly associated with chronic pancreatitis. Gastroenterology 117, 7–10 (1999).

    Article  CAS  Google Scholar 

  5. Le Maréchal, C. et al. Hereditary pancreatitis caused by triplication of the trypsinogen locus. Nat. Genet. 38, 1372–1374 (2006).

    Article  Google Scholar 

  6. Teich, N. et al. Mutations of human cationic trypsinogen (PRSS1) and chronic pancreatitis. Hum. Mutat. 27, 721–730 (2006).

    Article  CAS  Google Scholar 

  7. Sahin-Tóth, M. Biochemical models of hereditary pancreatitis. Endocrinol. Metab. Clin. North Am. 35, 303–312 (2006).

    Article  Google Scholar 

  8. Witt, H. et al. Mutations in the gene encoding the serine protease inhibitor, Kazal type 1 are associated with chronic pancreatitis. Nat. Genet. 25, 213–216 (2000).

    Article  CAS  Google Scholar 

  9. Pfützer, R.H. et al. PSTI/SPINK1 polymorphisms act as disease modifiers in familial and idiopathic chronic pancreatitis. Gastroenterology 119, 615–623 (2000).

    Article  Google Scholar 

  10. Witt, H. et al. Mutation in the SPINK1 trypsin inhibitor gene, alcohol use, and chronic pancreatitis. J. Am. Med. Assoc. 285, 2716–2717 (2001).

    Article  CAS  Google Scholar 

  11. Chandak, G.R. et al. Mutations in the pancreatic secretory trypsin inhibitor gene (PSTI/SPINK1) rather than the cationic trypsinogen gene (PRSS1) are significantly associated with tropical calcific pancreatitis. J. Med. Genet. 39, 347–351 (2002).

    Article  CAS  Google Scholar 

  12. Bhatia, E. et al. Tropical calcific pancreatitis: strong association with SPINK1 trypsin inhibitor mutations. Gastroenterology 123, 1020–1025 (2002).

    Article  CAS  Google Scholar 

  13. Schneider, A. et al. SPINK1/PSTI mutations are associated with tropical pancreatitis and type II diabetes mellitus in Bangladesh. Gastroenterology 123, 1026–1030 (2002).

    Article  CAS  Google Scholar 

  14. Király, O., Wartmann, T. & Sahin-Tóth, M. Missense mutations in pancreatic secretory trypsin inhibitor (SPINK1) cause intracellular retention and degradation. Gut 56, 1433–1438 (2007).

    Article  Google Scholar 

  15. Boulling, A. et al. Functional analysis of pancreatitis-associated missense mutations in the pancreatic secretory trypsin inhibitor (SPINK1) gene. Eur. J. Hum. Genet. 15, 936–942 (2007).

    Article  CAS  Google Scholar 

  16. Witt, H. et al. A degradation-sensitive anionic trypsinogen (PRSS2) variant protects against chronic pancreatitis. Nat. Genet. 38, 668–673 (2006).

    Article  CAS  Google Scholar 

  17. Szmola, R. & Sahin-Tóth, M. Chymotrypsin C (caldecrin) promotes degradation of human cationic trypsin: identity with Rinderknecht's enzyme Y. Proc. Natl. Acad. Sci. USA 104, 11227–11232 (2007).

    Article  CAS  Google Scholar 

  18. Jessop, N.W. & Hay, R.J. Characteristics of two rat pancreatic exocrine cell lines derived from transplantable tumors. In Vitro 16, 212 (1980).

    Google Scholar 

Download references

Acknowledgements

We thank the individuals who have participated in this study. We also thank A. Schulzki, M. Braun and V. Sahin-Tóth for excellent technical assistance. This work was supported by US National Institutes of Health grant DK058088 (to M.S.-T.), a scholarship from the Rosztoczy Foundation (to B.O.), by the Medical Faculty of the University of Leipzig formel.1 (to J.R.), and the Deutsche Forschungsgemeinschaft (DFG) grant Te 352/2-1 (to N.T.) and grants Wi 2036/2-1 and Wi 2036/2-2 (to H.W.).

Author information

Authors and Affiliations

Authors

Contributions

M.S.-T., N.T. and H.W. conceived, designed and directed the study. J.R. and H.W. designed, performed and interpreted genetic analyses. R.S., M.S.-T. and B.O. carried out functional characterization of CTRC variants. M.S.-T. wrote the manuscript with significant contributions from R.S., H.W. and J.R. O.L. provided oligonucleotides. N.T., J.R., H.W. and all other coauthors recruited patients and control subjects, collected clinical data and provided genomic DNA samples. All authors approved the final manuscript and contributed critical revisions to its intellectual content.

Corresponding author

Correspondence to Miklós Sahin-Tóth.

Supplementary information

Supplementary Text and Figures

Supplementary Figures 1 and 2, Supplementary Tables 1 and 2, Supplementary Methods (PDF 86 kb)

Rights and permissions

Reprints and permissions

About this article

Cite this article

Rosendahl, J., Witt, H., Szmola, R. et al. Chymotrypsin C (CTRC) variants that diminish activity or secretion are associated with chronic pancreatitis. Nat Genet 40, 78–82 (2008). https://doi.org/10.1038/ng.2007.44

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/ng.2007.44

This article is cited by

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing